Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SLC35D2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA564148
Description
Immunogen sequence: YSFLTLSSQL KPKPVGEENI CLD Highest antigen sequence identity to the following orthologs: Mouse - 83%, Rat - 75%.
Antiporter transporting nucleotide sugars such as UDP-N-acetylglucosamine (UDP-GlcNAc), UDP-glucose (UDP-Glc) and GDP-mannose (GDP-Man) pooled in the cytosol into the lumen of the Golgi in exchange for the corresponding nucleosides monophosphates (UMP for UDP-sugars and GMP for GDP-sugars). May take part in heparan sulfate synthesis by supplying UDP-Glc-NAc, the donor substrate, and thus be involved in growth factor signaling.
Specifications
SLC35D2 | |
Polyclonal | |
Unconjugated | |
SLC35D2 | |
5730408I21Rik; fringe connection; hfrc; HFRC1; Homolog of Fringe connection protein 1; mUGTrel8; SLC35D2; solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2; solute carrier family 35 member D2; solute carrier family 35, member D2; SQV7L; SQV7-like protein; UDP-galactose transporter-related protein 8; UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter; UDP-N-acetylglucosamine transporter; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter; UGTrel8 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
11046 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.05 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q76EJ3 | |
SLC35D2 | |
Recombinant protein corresponding to Human SLC35D2. Recombinant protein control fragment (Product #RP-103541). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction